Trials / Completed
CompletedNCT00743119
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- New York State Psychiatric Institute · Academic / Other
- Sex
- Female
- Age
- 21 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The following study is designed to determine the analgesic efficacy of smoked marijuana (0, 1.98, and 3.56% THC) and oral THC (0, 10, and 20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Oral THC (dronabinol) is known to have a slower onset and longer duration of action compared with smoked marijuana. Therefore, the analgesic effects of oral THC is expected to peak later and last longer than effects produced by smoked marijuana.
Detailed description
Laboratory animal studies have demonstrated the analgesic effects of drugs which act on the cannabinoid system, however, these effects have et to be clearly elucidated in humans. To better understand the potential clinical application of cannabinoids for pain management, the following study is designed to determine the analgesic efficacy of smoked marijuana (3.56% THC) and oral THC (20 mg) in the Cold-Pressor Test (CPT), a laboratory model of pain which has predictive validity for clinical use of analgesics. Non-treatment seeking marijuana smokers will be recruited for a five-session study during which the analgesic, subjective, and physiologic effects of cannabinoids will be evaluated. Determining the efficacy of cannabinoids in an experimental model of pain will provide important endpoints (i.e., dose, route of administration, time course) or this effect to further investigate the potential role for clinical use of smoked marijuana and/or oral THC as analgesics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo capsules | Placebo capsules |
| DRUG | Inactive marijuana (0% THC) | Inactive marijuana cigarettes (0% THC) provided by NIDA |
| DRUG | Low dose Dronabinol | Dronabinol 10mg |
| DRUG | High dose Dronabinol | Dronabinol 20mg |
| DRUG | Low THC marijuana | marijuana cigarettes (1.98% THC) provided by NIDA |
| DRUG | High THC marijuana | Marijuana cigarettes (3.56% THC) provided by NIDA |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-10-01
- Completion
- 2013-05-01
- First posted
- 2008-08-28
- Last updated
- 2017-12-11
- Results posted
- 2017-12-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00743119. Inclusion in this directory is not an endorsement.